Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
Scientists find promising avenue to restore cognitive function impaired by Alzheimer's disease
A team of neuroscientists has identified a potential means to address the loss of cognitive function due to Alzheimer's disease by targeting protein synthesis in mice.
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
DUBLIN and LONDON, Feb.
Amgen cuts 500 U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital
Amgen is cutting 500 jobs, and its U.
Drug metformin can affect breast cancer risk in women with diabetes
In a new study, researchers found that there appears to be no association between type 2 diabetes and developing breast cancer overall.
Horizon Therapeutics to Purchase Viela Bio for $3.1 Billion
Horizon Therapeutics Plc said it will purchase Viela Bio Inc.
Study Supports Delay of Second Dose of AstraZeneca's COVID-19 Vaccine
Although designed for two doses, primary analysis of AstraZeneca and the University of Oxford’s Phase III data for its COVID-19 vaccine found it to have 76% efficacy after the first dose.
Bristol Myers psoriasis drug succeeds in late-stage study
(Reuters) - Bristol Myers Squib said on Tuesday its experimental oral drug for plaque psoriasis significantly reduced the extent and severity of the skin condition and was more effective than ...
Vaccine manufacturing greenhorn Bayer to make 160M doses of CureVac's COVID-19 shot
In its nearly 160-year history, Bayer has never produced vaccines for humans.
Bristol Myers Squibb Application for Zeposia® (ozanimod) for the Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by U.S. Food and Drug Administration
PRINCETON, NJ, USA I February 01, 2021Bristol Myers Squibb (NYSE.
Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa
BEDMINSTER, NJ, USA I February 01, 2021 IMatinas BioPharma Holdings, Inc.
Eli Lilly's COVID-19 antibody picks up $871M in Q4—and carries blockbuster hopes for 2021
Eli Lilly's COVID-19 antibody stole the show during the fourth quarter, and the company says there's more to come as the U.
Invasive candidiasis treatment rezafungin wins orphan drug status
Mundipharma and Cidara Therapeutics’ rezafungin has been granted an orphan drug designation from the European Commission for the treatment of invasive candidiasis (IC).
68
69
70
71
72
73
74
75
76
